WO2015186139A3 - Novel polymorphs of tenofovir disoproxil oxalate and process for preparation of the same - Google Patents

Novel polymorphs of tenofovir disoproxil oxalate and process for preparation of the same Download PDF

Info

Publication number
WO2015186139A3
WO2015186139A3 PCT/IN2015/000225 IN2015000225W WO2015186139A3 WO 2015186139 A3 WO2015186139 A3 WO 2015186139A3 IN 2015000225 W IN2015000225 W IN 2015000225W WO 2015186139 A3 WO2015186139 A3 WO 2015186139A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
same
tenofovir disoproxil
novel polymorphs
disoproxil oxalate
Prior art date
Application number
PCT/IN2015/000225
Other languages
French (fr)
Other versions
WO2015186139A2 (en
Inventor
Ravindra Babu Bollu
Veera Venkata Krishna Kishore Jammula
Venkata Sunil Kumar Indukuri
Seeta Rama Anjaneyulu GORANTLA
Satyanarayana Chava
Original Assignee
Laurus Labs Private Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laurus Labs Private Limited filed Critical Laurus Labs Private Limited
Publication of WO2015186139A2 publication Critical patent/WO2015186139A2/en
Publication of WO2015186139A3 publication Critical patent/WO2015186139A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to novel polzmorphs of tenofovir disoproxil oxalate, process for its preparation and pharmaceutical composition comprising the same.
PCT/IN2015/000225 2014-06-02 2015-05-29 Novel polymorphs of tenofovir disoproxil oxalate and process for preparation of the same WO2015186139A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2687CH2014 2014-06-02
IN2687/CHE/2014 2014-06-02

Publications (2)

Publication Number Publication Date
WO2015186139A2 WO2015186139A2 (en) 2015-12-10
WO2015186139A3 true WO2015186139A3 (en) 2016-01-28

Family

ID=54767522

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2015/000225 WO2015186139A2 (en) 2014-06-02 2015-05-29 Novel polymorphs of tenofovir disoproxil oxalate and process for preparation of the same

Country Status (1)

Country Link
WO (1) WO2015186139A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111759850A (en) * 2020-08-17 2020-10-13 深圳市道科思医药有限公司 Pharmaceutical composition of tenofovir oxalate

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009074351A2 (en) * 2007-12-12 2009-06-18 Ultimorphix Technologies B.V. Solid forms of tenofovir disoproxil

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009074351A2 (en) * 2007-12-12 2009-06-18 Ultimorphix Technologies B.V. Solid forms of tenofovir disoproxil

Also Published As

Publication number Publication date
WO2015186139A2 (en) 2015-12-10

Similar Documents

Publication Publication Date Title
WO2016011222A3 (en) Circular polynucleotides
WO2016011306A3 (en) Terminal modifications of polynucleotides
MX2017014035A (en) Solid forms.
WO2015191945A3 (en) Solid state forms of sofosbuvir
WO2015104658A3 (en) Amorphous solid dispersion of dapagliflozin and process for the preparation of amorphous dapagliflozin
WO2016092561A3 (en) Novel polymorphs of ivacaftor, process for its preparation and pharmaceutical composition thereof
WO2016009401A3 (en) Preparation of tedizolid phosphate
PH12016501686A1 (en) Pharmaceutical compositions of sitagliptin
WO2015121877A3 (en) Polymorphs of lomitapide and its salts
WO2016013030A3 (en) Hydroxysteroid compounds, their intermediates, process of preparation, composition and uses thereof
WO2015092810A3 (en) Amorphous form of idelalisib
WO2017008136A3 (en) Flourinated cbd compounds, compositions and uses thereof
WO2016166720A3 (en) Polymorphs of afatinib and its salts and process for the preparation of quinazolinyl derivatives
EP3694499A4 (en) Novel process for the preparation of lifitegrast
IN2014CH00840A (en)
WO2015181802A3 (en) Oral pharmaceutical composition of isotretinoin
WO2016024289A3 (en) Novel salts of nilotinib and polymorphs thereof
EP3501524A4 (en) Use as immune enhancer or pharmaceutical composition for treatment of dementia, comprising phytosphingosine-1-phosphate or derivative thereof
WO2016063289A3 (en) Pharmaceutical tablet compositions comprising rifaximin
WO2015052568A3 (en) Solid forms of curcumin and derivatives thereof
EP3244895A4 (en) Novel pharmaceutical composition
WO2017029642A3 (en) Novel polymorphs of dolutegravir and salts thereof
WO2014195977A3 (en) Novel polymorphs of vismodegib
WO2014159501A3 (en) Processes for preparing tetrahydroisoquinolines
WO2014128728A3 (en) Solid forms of cabazitaxel and processes for preparation thereof

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15803074

Country of ref document: EP

Kind code of ref document: A2